AXDND1
Axonemal dynein light chain domain-containing protein 1
Also known as: AXDN1_HUMAN, C1orf125, FLJ32940
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5T1B0
- Gene
- AXDND1
- Ensembl
- ENSG00000162779
- Chromosome
- 1
- Canonical length
- 1012 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Primary cilium,Basal body,Cytosol
OverviewNCBI Gene
Predicted to be involved in manchette assembly. Located in ciliary basal body and cytosol. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1012 residues, UniProt reviewed canonical sequence.
>Q5T1B0|AXDND1
1 MSLPKTPSTP LNSTSTSESK KLKVSVAKEG TRGLPELKEK KNMVDRSKLL PTSLQNEFIP
61 KEVLLSLTYA ANAGPCPENL LPPKKIKTPK GTLPRLVDHV WHHPVRRNKF KYLIDHPVSL
121 TGAGRDISFL YDVTYAKGQT REKAVCPPHL ARSLQSHDGV IVPHKPKTLT DTLIPEEFHI
181 VSSTGVSGLE CYDDKYTTLL TDSENRLLLF PSMKPNKRVE VAQLNDVMDT MLERAGVENQ
241 EYTGPTKMHK LLHILKKEQT IYNMIFHELI RQVSVDCADR GELLSKVRER YVQMLDQIAR
301 QMIDFYKDLV TQRVMDQRIL EELYNFKHVI EELTRELCLV RAHDVKLTKE TEKAHKDLAQ
361 ALLNAEKNAK IVEEYHDLYT LQRERMENDM KKLVAERDIW SSATYELALK VIERNRVILA
421 RRLYLNEKGW NKYTKHFIIL LSNKDTEDLA LLQKLTQKWR NLVNKLKQEV EQMEESTSET
481 LKIVKDGLIK WQEFFNEKDI LSPNKGNIFN SVLLDFKQWQ KILNEKKEEF TGDVLLSKYD
541 TLKIIKHLQE NWADIGLGIF NRHKSLEGEM PSERQYMEEI IKNIQKLYKE YEIRINGDNG
601 YSKILPSLIS SLDFCSFKLE NLEFPDTPLE EWQEIDEKIN EMKSHLDILL NLTGIVPQHI
661 DVDSVSVLQA YIFNMIQQWL LKIGNEINNG NIELQHHMDE LHISMIQWMV NLLILMIPNF
721 TDQDCLLKLE EESAEKHDIG VARLELDAIE LTRKLYQYSS YLSSCCKGMV TAMALSKSTN
781 SHKNATEDLY EVDKLKKECY EWINTCSCLL SNIKGRKITL LTYEEIERLL EEEAVKEFIE
841 PEIDESFKED EEESKEDRKL QEENKERAEE QPSTSTEKEK LIRFIGEDEN VHSKPLFETD
901 VLSSWRESAK QGTLAQKYLE AMAVIEHMQE KLLEVENRAR QAEEKFEDAY EKLHHTLIKN
961 KDLEELVMTS RKESKEEKEN QDEREVKEEE EQQEEEEVRS AENSSKSPKK GHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AXDND1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- testis: 15 nTPM
- epididymis: 0.4 nTPM
- adrenal gland: 0.3 nTPM
- choroid plexus: 0.3 nTPM
- colon: 0.2 nTPM
- fallopian tube: 0.2 nTPM
Single-cell type
- late spermatids: 425 nCPM
- late primary spermatocytes: 246 nCPM
- early spermatids: 242 nCPM
- ependymal cells: 93 nCPM
- foveolar cells: 62 nCPM
- podocytes: 49 nCPM
Immune cell
- neutrophil: 0.3 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- midbrain: 1 nTPM
- choroid plexus: 0.9 nTPM
- spinal cord: 0.9 nTPM
- medulla oblongata: 0.7 nTPM
- white matter: 0.7 nTPM
- basal ganglia: 0.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AXDND1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 156 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.3
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Axonemal dynein light chain
- Axonemal dynein light chain
- Axonemal dynein light chain domain-containing protein
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AXDND1 as an antibody target. Whether an autoantibody or antibody against AXDND1 could matter depends on whether native AXDND1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AXDND1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AXDND1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...